Ghias Babar - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 17, 2025, Ghias Babar's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Officer (Chief Financial Officer), and currently has 268,700 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BCRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Ghias Babar - Insider Non-Derivative Transactions of BCRX Common Stock

Ghias Babar - Insider Non-Derivative Transactions at BCRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 18, 2025	Acquisition -- (Common Stock)	121700	0	268700
Jul 25, 2025	Acquisition -- (Common Stock)	147000	0	147000